2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
15
Lung Neoplasms
11
Colonic Neoplasms
10
Breast Neoplasms
9
Brain Neoplasms
7
Prostatic Neoplasms
4
Emergence Delirium
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Respiratory Aspiration
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Neoplastic Cells, Circulating
3
Hypoxia
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Agnosia
3
Supratentorial Neoplasms
2
Postoperative Complications
2
Patient Satisfaction
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Liver Neoplasms
2
Leukemia
2
Delirium
2
Colorectal Neoplasms
2
Abdominal Neoplasms
2
Interventions
Morphine
16
Oxycodone
14
Fentanyl
10
Methadone
7
nabiximols
5
Lidocaine
5
Acetaminophen
5
resiniferatoxin
4
Hydromorphone
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Buprenorphine
3
Transcranial Direct Current Stimulation
2
Tapentadol
2
Surveys and Questionnaires
2
Standard of Care
2
Sodium Bicarbonate
2
Radiosurgery
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Naloxone
2
Ketamine
2
Electroacupuncture
2
Dronabinol
2
Control Groups
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer Pain
×
Propofol
×
Clear all
NCT06644573
2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1
Not yet recruiting
100 enrolled